全文获取类型
收费全文 | 2131篇 |
免费 | 143篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 104篇 |
妇产科学 | 11篇 |
基础医学 | 320篇 |
口腔科学 | 14篇 |
临床医学 | 244篇 |
内科学 | 451篇 |
皮肤病学 | 29篇 |
神经病学 | 271篇 |
特种医学 | 114篇 |
外国民族医学 | 1篇 |
外科学 | 286篇 |
综合类 | 4篇 |
预防医学 | 106篇 |
眼科学 | 25篇 |
药学 | 114篇 |
肿瘤学 | 158篇 |
出版年
2023年 | 23篇 |
2022年 | 44篇 |
2021年 | 104篇 |
2020年 | 52篇 |
2019年 | 90篇 |
2018年 | 102篇 |
2017年 | 71篇 |
2016年 | 79篇 |
2015年 | 94篇 |
2014年 | 113篇 |
2013年 | 135篇 |
2012年 | 156篇 |
2011年 | 150篇 |
2010年 | 75篇 |
2009年 | 76篇 |
2008年 | 92篇 |
2007年 | 88篇 |
2006年 | 75篇 |
2005年 | 58篇 |
2004年 | 60篇 |
2003年 | 48篇 |
2002年 | 64篇 |
2001年 | 13篇 |
2000年 | 26篇 |
1999年 | 22篇 |
1998年 | 8篇 |
1997年 | 13篇 |
1996年 | 11篇 |
1995年 | 12篇 |
1994年 | 7篇 |
1993年 | 15篇 |
1992年 | 24篇 |
1991年 | 17篇 |
1990年 | 27篇 |
1989年 | 22篇 |
1988年 | 13篇 |
1987年 | 24篇 |
1986年 | 25篇 |
1985年 | 30篇 |
1984年 | 17篇 |
1983年 | 19篇 |
1982年 | 7篇 |
1981年 | 11篇 |
1980年 | 7篇 |
1979年 | 6篇 |
1978年 | 7篇 |
1977年 | 8篇 |
1975年 | 7篇 |
1974年 | 6篇 |
1970年 | 5篇 |
排序方式: 共有2277条查询结果,搜索用时 531 毫秒
61.
Yu-Te Hsu Mt Hartstein Alexander J. Davies Alexander J. Hickey Mun K. Chan Juan Porras Toshinao Loew Sofia V. Taylor Hsu Liu Alexander G. Eaton Matthieu Le Tacon Huakun Zuo Jinhua Wang Zengwei Zhu Gilbert G. Lonzarich Bernhard Keimer Neil Harrison Suchitra E. Sebastian 《Proceedings of the National Academy of Sciences of the United States of America》2021,118(7)
62.
Lapierre V Aupérin A Tayebi H Chabod J Saas P Michalet M François S Garban F Giraud C Tramalloni D Oubouzar N Blaise D Kuentz M Robinet E Tiberghien P;Société Française de Greffe de Moelle et de Thérapiue Cellulaire 《Blood》2002,100(4):1484-1489
We have recently shown that the use of allogeneic granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood hematopoietic stem cell transplantation (PBHSCT), as compared with bone marrow transplantation (BMT), is associated with increased titers of antibodies (Abs) directed against red blood cell ABO antigens. To further evaluate the influence of a G-CSF-mobilized PBHSCT graft on alloimmune Ab responses, we examined the frequency of anti-HLA Abs after transplantation in the setting of the same randomized study, comparing PBHSCT with BMT in adults. Anti-HLA Ab presence was determined by complement-dependent cytotoxicity assay (CDC) and flow cytometry in the recipient before and 30 days after transplantation as well as in the donor before graft donation. The use of PBHSCT was significantly associated with increased detection of anti-HLA immunoglobulin G (IgG) Abs early after transplantation as evidenced by flow cytometry (11 of 24 versus 4 of 27 transplant recipients, P =.03) and, less so, by CDC (5 of 24 versus 1 of 27 transplant recipients, P =.09). The difference between PBHSCT and BMT was further heightened when analysis was restricted to anti-HLA IgG Ab-negative donor/recipient pairs. In such a setting, early anti-HLA Ab was never detected after BMT but was repeatedly detected after PBHSCT (flow cytometry, 6 of 18 versus 0 of 17 transplant recipients, P =.02; CDC, 4 of 23 versus 0 of 26 transplant recipients, P =.04). Importantly, the PBHSCT-associated increase in anti-HLA Ab detection was observed despite a reduction in the median number of platelet-transfusion episodes per patient in PBHSC transplant versus BM transplant recipients (3 platelet-transfusion episodes [range, 1-21] in PBHSCT group vs 6 platelet-transfusion episodes [range, 3-33] in the BMT group; P =.02). In conclusion, this study strongly suggests that G-CSF-mobilized PBHSCT results in an increased incidence of circulating anti-HLA Abs and further confirms that the use of such a graft alters alloimmune Ab responses. 相似文献
63.
David Sevrain Matthieu Dubreuil Grace Elizabeth Dolman Abed Zaitoun William Irving Indra Neil Guha Christophe Odin Yann Le Grand 《Biomedical optics express》2015,6(4):1209-1218
In this paper we analyze a fibrosis scoring method based on measurement of the fibrillar collagen area from second harmonic generation (SHG) microscopy images of unstained histological slices from human liver biopsies. The study is conducted on a cohort of one hundred chronic hepatitis C patients with intermediate to strong Metavir and Ishak stages of liver fibrosis. We highlight a key parameter of our scoring method to discriminate between high and low fibrosis stages. Moreover, according to the intensity histograms of the SHG images and simple mathematical arguments, we show that our area-based method is equivalent to an intensity-based method, despite saturation of the images. Finally we propose an improvement of our scoring method using very simple image processing tools.OCIS codes: (180.4315) Nonlinear microscopy, (170.1610) Clinical applications, (170.3880) Medical and biological imaging, (170.4580) Optical diagnostics for medicine, (110.2960) Image analysis 相似文献
64.
65.
Didier M. Payen Joelle Guilhot Yoann Launey Anne Claire Lukaszewicz Mahmoud Kaaki Benoit Veber Julien Pottecher Olivier Joannes-Boyau Laurent Martin-Lefevre Matthieu Jabaudon Olivier Mimoz Rémi Coudroy Martine Ferrandière Eric Kipnis Carlos Vela Stéphanie Chevallier Jihad Mallat René Robert The ABDOMIX Group 《Intensive care medicine》2015,41(6):975-984
66.
Real‐time in vivo periprostatic nerve tracking using multiphoton microscopy in a rat survival surgery model: a promising pre‐clinical study for enhanced nerve‐sparing surgery
下载免费PDF全文
![点击此处可从《BJU international》网站下载免费的PDF全文](/ch/ext_images/free.gif)
67.
Successful treatment of pulmonary mucormycosis in an allogenic bone-marrow transplant recipient with combined medical and surgical therapy 总被引:2,自引:0,他引:2
Pavie J Lafaurie M Lacroix C Marie Zagdanski A Debrosse D Socié G Derouin F Gluckman E Michel Molina J 《Scandinavian journal of infectious diseases》2004,36(10):767-769
Mucormycosis is a rare, but severe, complication in allogenic bone-marrow recipients with a mortality rate of about 80%. Moreover, its incidence appears to have increased within the last decade. We report a case of pulmonary and nasal mucormycosis in a 55-y-old patient, which occurred 1 y after BMT. Treatment combining 4 months of amphotericin B, early surgical resection of infected tissue and discontinuation of immunosuppressive treatment allowed the cure of this mould infection. 相似文献
68.
69.
Delphine Bonnet Matthieu Guivarch Ana?s Palacin Laurent Alric Emilie Bérard Jean-Marc Combis Andre Jean Remy Andre Glibert Jean-Louis Payen Sophie Metivier Karl Barange Herve Desmorat Florence Nicot Florence Abravanel 《World journal of hepatology》2014,6(9):660-669
AIM:To assess,in a routine practice setting,the sus-tained virologic response(SVR) to telaprevir(TPV) or boceprevir(BOC) in hepatitis C virus(HCV) nullresponders or relapsers with severe liver fibrosis.METHODS:One hundred twenty-five patients were treated prospectively for 48 wk with TPV or BOC + pegylated-interferon(peg-INF) α2a + ribavirin(PR) according to standard treatment schedules without randomization.These patients were treated in routine practice settings in 10 public or private health care centers,and the data were prospectively collected.Only patients with severe liver fibrosis(Metavir scores of F3 or F4 upon liver biopsy or liver stiffness assessed by elastography),genotype 1 HCV and who were null-responders or relapsers to prior PR combination therapy were included in this study.RESULTS:The Metavir fibrosis scores were F3 in 35(28%) and F4 in 90(72%) of the patients.In total,62.9% of the patients were null-responders and 37.1% relapsers to the previous PR therapy.The overall SVR rate at 24 wk post-treatment withdrawal was 59.8%.The SVR was 65.9% in the TPV group and 44.1% in the BOC group.Independent predictive factors of an SVR included a response to previous treatment,relapsers vs null-responders [OR = 3.9;(1.4,10.6),P = 0.0084],a rapid virological response(RVR) [OR 6.9(2.6,18.2),P = 0.001] and liver stiffness lower than 21.3 kPa [OR = 8.2(2.3,29.5),P = 0.001].During treatment,63 patients(50.8%) had at least one severe adverse event(SAE) of grade 3 or 4.A multivariate analysis identified two factors associated with SAEs:female gender [OR = 2.4(1.1,5.6),P = 0.037] and a platelet count below 150 × 103/ mm3 [OR = 5.3(2.3,12.4),P ≤ 0.001].CONCLUSION:More than half of these difficult-to-treat patients achieved an SVR and had SAEs in an actual practice setting.The SVR rate was influenced by the response to previous PR treatment,the RVR and liver stiffness. 相似文献